Urethral Neoplasms Clinical Trials

Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions: Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations: Yale University School of Medicine New Haven, Connecticut, United States

Florida Cancer Specialists Fort Myers, Florida, United States

Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States

Tennessee Oncology PLLC Chattanooga, Tennessee, United States

View all 22 locations

View Trial Details

Completed

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

NCT03513952

Conditions: Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
Locations: Kaiser Permanente-Riverside Riverside, California, United States

Moffitt Cancer Center Tampa, Florida, United States

Straub Clinic and Hospital Honolulu, Hawaii, United States

University of Hawaii Cancer Center Honolulu, Hawaii, United States

View Trial Details

Completed

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

NCT01326871

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +20 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

UF Health Center at Orlando Health Orlando, Florida, United States

Martin Health System Stuart, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 16 locations

View Trial Details

Completed

UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

NCT02643043

Conditions: Bladder Cancer, Cancer of the Ureter, Carcinoma, +20 more
Locations: University of Southern Cailfornia Los Angeles, California, United States

University of Chicago Medical Center Chicago, Illinois, United States

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Ichan School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer

NCT02426125

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations: Highlands Oncology Group Fayetteville, Arkansas, United States

St. Jude Medical Center Fullerton, California, United States

UCLA Medical Center Los Angeles, California, United States

USC Norris Cancer Hospital Los Angeles, California, United States

View all 141 locations

View Trial Details

Completed

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

NCT00053209

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

Porter Adventist Hospital Denver, Colorado, United States

View all 121 locations

View Trial Details

Completed

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

NCT00003376

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States

University of California San Diego Cancer Center La Jolla, California, United States

UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States

Veterans Affairs Medical Center - San Francisco San Francisco, California, United States

View all 50 locations

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

NCT00005644

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

CCOP - Kalamazoo Kalamazoo, Michigan, United States

Veterans Affairs Medical Center - East Orange East Orange, New Jersey, United States

James P. Wilmot Cancer Center Rochester, New York, United States

View all 16 locations

View Trial Details

Completed

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00002914

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Emory University Hospital - Atlanta Atlanta, Georgia, United States

Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States

View all 29 locations

View Trial Details

Completed

Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

NCT00004223

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States

Stanford University Medical Center Stanford, California, United States

View all 76 locations

View Trial Details

Urethral Neoplasms

Urethral Neoplasms trial results

Related conditions